Turing reneges on drug price cut, rival's version sells well
TRENTON, N.J. - After weeks of criticism from patients, doctors and even other drugmakers for hiking a life-saving medicine's price more than fifty-fold, Turing Pharmaceuticals is reneging on its pledge to cut the $750-per-pill price.
Instead, the small biotech company says it's reducing the price for hospitals by up to 50 percent for its Daraprim, which treats a rare parasitic infection that mainly strikes pregnant women and HIV patients.
The 62-year-old drug had no competition until a furor over the gigantic price hike erupted, triggering multiple government investigations.
Then a pharmacy that compounds prescription drugs for individual patients stepped in and started selling a capsule version for 99 cents. Imprimis Pharmaceuticals says orders are pouring in from doctors and it says it has dispensed more than 2,500 capsules in barely a month.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
2MAD: Women United providing single moms, families with fresh food amid pandemic
Former LSU track star mourns younger brother's death, killed in S. Flannery...
New BRPD task force to heighten night patrol in high crime areas
After one week, 60 participants enrolled in Baton Rouge COVID-19 vaccine clinical...
Read the SEC's coronavirus medical protocols